Expression of the G2/M checkpoint protein p21 increased in tumours treated with ATR inhibitor, while levels of both Top2A and the apoptosis inhibitor Survivin decreased, in agreement with RNA levels (Fig. 7e). This evidence concerns the gene CDKN1A and neoplasm.